A*STAR and MSD team up to advance peptide therapeutics
19 July 2016 | By Niamh Louise Marriott
A*STAR and MSD have formed a two year collaboration aimed at improving cellular delivery of macrocyclic peptides...
List view / Grid view
19 July 2016 | By Niamh Louise Marriott
A*STAR and MSD have formed a two year collaboration aimed at improving cellular delivery of macrocyclic peptides...
11 July 2016 | By Victoria White, Digital Content Producer
An international project to develop a large, globally accessible, bank of new cancer models for the research community launches today...
8 July 2016 | By Victoria White, Digital Content Producer
Scientists have identified the 'cell of origin' in basal cell carcinoma and followed the chain of events that lead to the growth of these invasive tumours...
7 July 2016 | By Victoria White, Digital Content Producer
Researchers have compared genetic mutations in tumours to those in cancer cell lines and then tested the cell lines' responses to therapeutic compounds...
4 July 2016 | By Victoria White, Digital Content Producer
Scientists have shown that NEAT1, a non-coding RNA, plays an important role in the survival of highly dividing cells - and in particular of cancer cells...
29 June 2016 | By Victoria White, Digital Content Producer
Moderna and MSD will develop personalised cancer vaccines that utilise Moderna’s mRNA vaccine technology to encode a patient’s specific neoantigens...
28 June 2016 | By Victoria White, Digital Content Producer
Combining engineered anthrax toxin proteins and existing chemotherapy drugs could potentially yield a therapy to reduce or eliminate cancerous tumours...
27 June 2016 | By European Society of Clinical Microbiology and Infectious Diseases (ESCMID)
ESCMID and ASM are jointly organising a conference to help researchers accelerate the development of new antimicrobials for drug-resistant infections...
23 June 2016 | By Victoria White, Digital Content Producer
Scientists have developed a magnetically controlled drug that can be condensed on a blood clot by means of a magnetic field...
22 June 2016 | By Victoria White, Digital Content Producer
Four cancer centres in the US are coming together in a new consortium to accelerate the discovery and development of novel cancer therapeutics...
20 June 2016 | By Victoria White, Digital Content Producer
Researchers have developed an innovative nanoplatform that allows them to effectively deliver RNAi agents to the sites of cancer and suppress tumour growth...
20 June 2016 | By Victoria White, Digital Content Producer
We recently caught up with Frank Pasqualone of Theravance Biopharma to find out about the latest study results for the company's antibiotic, Vibativ...
20 June 2016 | By Victoria White, Digital Content Producer
The funding, led by Epidarex Capital, will support the Mironid’s internal research and preclinical development programmes...
20 June 2016 | By Victoria White, Digital Content Producer
The new findings on thalidomide, from researchers at the Technical University of Munich (TUM), are highly relevant to current cancer therapies...
17 June 2016 | By Victoria White, Digital Content Producer
Cell Medica has entered into a co-development partnership with Baylor to develop technologies for engineering immune cells with enhanced functions...